Osteoporosis Flashcards
Describe the relationship between RANKL, RANK, and OPG in the regulation of osteoclast activation
- activation of osteoclasts requires signaling from osteoblasts
- RANKL expressed on osteoblasts in response to PTH–>RANKL on blasts activate RANK on clast precursors–>promotes differentiation
- OPG is a decoy receptor that bind to RANKL and prevents it from activating RANK
how does estrogen inhibit osteoclast function?
increases OPG production
Describe the relationship between circulating calcium levels and the release/production of active vitamin D, parathyroid hormone, and calcitonin
Decreased blood calcium–>PTH activated and increases osteoclast activity, increases Ca absorption in kidney, and increases activation of vit D (per kidney), leading to increased intestinal Ca absorption
-calcitonin is a peptide from C cells in thyroid–>when Ca blood levels are high, it decreases plasma calcium by inhibiting osteoclasts–>decreases resorption of bone (salmon calcitonin is used for this effect)
Describe the regulation of vitamin D production and its actions on circulating calcium levels and bone
(PTH helps regulate vit D)
chol is skin +UV–>1st vit D version–>liver adds 25-OH–>kidney adds another OH per PTH–>fully activated vit D–>inc. intestinal absorption of Ca
Describe the regulation of parathyroid hormone release and its actions on circulating calcium levels and bone
high blood Ca levels–>Ca binds to GPCR–>blocks mRNA and translation and inhibition of PTH secretion
-low blood ca–>inhibition removed from GPCR–>PTH released–> increases osteoclast activity, increases Ca absorption in kidney, increased vit D activation for intestinal absorption
What are the RFs for osteoporosis?
Understand that osteoporosis is a silent disease that may require prophylactic treatment in high risk individuals
- decreased estrogen: woman
- Ca or Vit D deficiency
- chronic glucocorticoid def.
- age–> > 50
Distinguish between medications that are anti-resorptive and anabolic
anti-resorptive: HRT, SERMs, salmon calcitonin, bisphosphonates, denosumab
anabolics: teriparatide
which drug is no longer recommended as a first line treatment for management in osteoporosis in post-menopausal women?
HRT
which drug is 1st line treatment of osteoporosis?
bisphosphonates
what side effect of bisphosphonates is extremely rare in pts taking it for osteoporosis. The risk is higher in what patient population?
osteonecrosis of the jaw
cancer pts taking high dose bisphosphonates for their tx
what is bisphosphonates major side effect?
GI and esophageal irritation